Genetic research allows not only for precise diagnosing of diseases, but also for selecting therapy and appropriate medicines, and for insight into future health condition. Genetic information obtained as a result of genetic research is related not only to patients, but to their relatives, too. In this context a threat arises of abuse, infringement of human rights and unauthorised access to genetic data. The audit of NIK was aimed, in the first place, to examine whether genetic research in Poland is conducted with due care for safety requirements, that is whether Polish legal regulations keep up with the development of modern technologies in medicine.
This article discusses the provisions for the legal protection of the human genome at the embryonic stage. I examine both the Polish and international regulations. I also look at the threats resulting from the development of genetic technologies and the need to introduce appropriate legal regulations for effective protection of the human being at the embryonic stage.
PL
W artykule podjęta została próba analizy regulacji dotyczących prawnej ochrony ludzkiego genomu na etapie embrionalnym. Analiza objęła zarówno unormowania krajowe, jak i międzynarodowe. Wskazane zostały również zagrożenia wynikające z rozwoju technologii genetycznych oraz związana z tym potrzeba wprowadzenia stosownych regulacji prawnych, pozwalających na zapewnienie skutecznej ochrony istocie ludzkiej na etapie embrionalnym
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.